Drug Approvals and Databases > Drug Trials Snapshots: EMFLAZA

Drug Approvals and Databases > Drug Trials Snapshots: EMFLAZA

A new DRUG TRIALS SNAPSHOT is now available.

EMFLAZA is a corticosteroid drug for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.

Drug Trials Snapshots provide information about who participated in clinical trials that supported the FDA approval of new drugs. The information provided in these Snapshots also highlights whether there were any differences in the benefits and side effects among sex, race and age groups.

See more Drug Trial Snapshots or contact us with questions at Snapshots@fda.hhs.gov.